papaverine and imatinib mesylate

papaverine has been researched along with imatinib mesylate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Ashok, C; Coumar, MS; Dyavaiah, M; Parcha, PK; Rajasekaran, B; Sarvagalla, S; Sudharshan, SJ	1

Other Studies

1 other study(ies) available for papaverine and imatinib mesylate

Article	Year
Repositioning antispasmodic drug Papaverine for the treatment of chronic myeloid leukemia. Pharmacological reports : PR, 2021, Volume: 73, Issue:2 Topics: Allosteric Site; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Binding Sites; Cell Line, Tumor; Drug Repositioning; Drug Synergism; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Molecular Docking Simulation; Molecular Dynamics Simulation; Papaverine; Parasympatholytics; RAW 264.7 Cells; Reactive Oxygen Species; Signal Transduction	2021

Article

Year

Repositioning antispasmodic drug Papaverine for the treatment of chronic myeloid leukemia.

Pharmacological reports : PR, 2021, Volume: 73, Issue:2

Topics: Allosteric Site; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Binding Sites; Cell Line, Tumor; Drug Repositioning; Drug Synergism; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Molecular Docking Simulation; Molecular Dynamics Simulation; Papaverine; Parasympatholytics; RAW 264.7 Cells; Reactive Oxygen Species; Signal Transduction

2021